Table 5 Comparisons of subscale scores for the self-report version of the DCGM-37 across gender, age group, economic status, and clinical characteristics

 Boys (n = 74)

61.3 ± 16.7

57.3 ± 18.2

59.4 ± 15.8*

65.8 ± 13.7

60.1 ± 16.1

56.3 ± 18.4

60.1 ± 12.8

 Girls (n = 66)

56.7 ± 16.1

52.4 ± 16.6

54.2 ± 12.4

65.3 ± 14.4

60.7 ± 13.2

57.6 ± 15.0

57.8 ± 9.4

 Effect size

0.28

0.29

0.38

0.04

0.04

0.08

0.21

 Children (n = 79)

56.6 ± 18.2*

52.0 ± 16.9*

56.8 ± 14.7

64.0 ± 13.9

58.3 ± 16.1

54.0 ± 18.6*

57.0 ± 12.0*

 Adolescents (n = 61)

62.4 ± 13.6

58.7 ± 17.7

57.2 ± 14.3

67.5 ± 13.9

62.9 ± 12.4

60.5 ± 13.5

61.0 ± 9.8

 Effect size

0.37

0.40

0.03

0.26

0.32

0.40

0.42

 High (n = 41)

64.0 ± 15.8 *

58.9 ± 16.7

61.6 ± 14.9 *

67.1 ± 13.3

63.7 ± 16.1

60.7 ± 16.9

62.7 ± 11.7 *

 Low (n = 97)

57.5 ± 16.5

53.6 ± 17.8

54.9 ± 13.9

64.7 ± 14.2

59.0 ± 14.1

55.0 ± 16.6

57.5 ± 10.9

 Effect size

0.50

0.38

0.58

0.21

0.40

0.41

0.58

 Leukaemias ^a (n = 80)

63.1 ± 16.2**

59.0 ± 16.0**

59.8 ± 15.0**

69.8 ± 11.7**

65.0 ± 13.0**

60.4 ± 14.8**

62.9 ± 10.4**

 Sarcoma ^b (n = 27)

52.5 ± 15.7

47.3 ± 20.1

48.8 ± 13.7

57.7 ± 16.4

50.8 ± 13.6

46.0 ± 15.9

55.6 ± 9.7

 Effect size

0.60

0.57

0.39

0.83

0.68

0.44

0.82